TGFB1 and neoplasm: On the other hand, the DHP column treatment to deplete LAP+ T cells in peripheral blood induced a decrease in the percentage of LAP+ T cells not only in peripheral blood but also in tumor tissues in addition to upregulation of CTL responses specific for tumor cells in spleen cells.